Key Takeaways
- • DeepSeek, an artificial intelligence company, reached a $50 billion valuation following its latest funding round as of June 18, 2026.
- • Original backers of Manus are pursuing a buyback of the company from Meta, signaling potential strategic repositioning in the AI sector.
- • KKR is targeting a majority stake acquisition in Medicover's Indian operations for at least $1 billion, reflecting continued private equity interest in healthcare assets in emerging markets.
Summary
DeepSeek has achieved a $50 billion valuation following a recent funding round, underscoring accelerating investor appetite for artificial intelligence companies in mid-2026. The valuation milestone reflects broader institutional confidence in the AI sector and DeepSeek's market position among competing AI development firms.
In parallel developments within the AI and technology investment landscape, original investors in Manus are negotiating a buyback of the company from Meta. This transaction signals potential strategic recalibration among AI-focused companies and their ownership structures, as founders and early backers seek to regain control of assets previously sold to larger technology platforms.
Additionally, private equity firm KKR has initiated negotiations to acquire a majority stake in the Indian operations of Medicover, the Swedish healthcare company, at a valuation of at least $1 billion. The move reflects KKR's continued expansion into healthcare infrastructure and emerging market opportunities, particularly within India's growing medical services sector.
These three transactions—spanning artificial intelligence valuations, AI company acquisitions, and healthcare private equity deals—reflect simultaneous momentum across venture capital, secondary markets, and private equity deal activity in June 2026. Collectively, they demonstrate institutional capital's focus on high-growth technology and healthcare sectors amid broader market conditions.
In parallel developments within the AI and technology investment landscape, original investors in Manus are negotiating a buyback of the company from Meta. This transaction signals potential strategic recalibration among AI-focused companies and their ownership structures, as founders and early backers seek to regain control of assets previously sold to larger technology platforms.
Additionally, private equity firm KKR has initiated negotiations to acquire a majority stake in the Indian operations of Medicover, the Swedish healthcare company, at a valuation of at least $1 billion. The move reflects KKR's continued expansion into healthcare infrastructure and emerging market opportunities, particularly within India's growing medical services sector.
These three transactions—spanning artificial intelligence valuations, AI company acquisitions, and healthcare private equity deals—reflect simultaneous momentum across venture capital, secondary markets, and private equity deal activity in June 2026. Collectively, they demonstrate institutional capital's focus on high-growth technology and healthcare sectors amid broader market conditions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.